NCT02956447View on ClinicalTrials.gov

Administration of Kisspeptin in Patients With Hyperprolactinemia

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

June 28, 2023

Study Completion Date

July 29, 2023

Conditions
HyperprolactinemiaHypogonadism
Interventions
DRUG

Kisspeptin 112-121

0.313 ug/kg - 2 ug/kg IV or SC

DRUG

GnRH

0.075 ug/kg IV

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02956447 - Administration of Kisspeptin in Patients With Hyperprolactinemia | Biotech Hunter | Biotech Hunter